Rilzabrutinib induces rapid, durable response in ITP, may become ‘new standard’
Results of the randomized phase 3 LUNA 3 study showed that rilzabrutinib…
European regulators approve $16.5B deal for Novo Holdings to buy Catalent
The European Commission approved Novo Holdings' $16.5 billion acquisition of Catalent, a…
Drug policy: Time to change punitive approach, says global report
Global drug policies should shift from punishing drug users to a public…
Bright light may lower depression symptoms by promoting better sleep
A study led by Brigham and Women's Hospital suggests that spending more…
Breakthrough in HWE reaction offers pathway for anti-cancer drug development
The Horner–Wadsworth–Emmons (HWE) reaction is crucial in organic chemistry for creating conjugated…
Physicians Offer Little Sympathy for Slain Insurance CEO
Physicians reacted harshly to the fatal shooting of UnitedHealthcare CEO Brian Thompson…
‘Will No Longer Be Going Into Effect Here’
Anthem Blue Cross Blue Shield in Connecticut has decided to cancel its…
Transforming Patient Care: The Role of AI-Powered Assistants
Artificial intelligence (AI) is transforming patient care by improving engagement, treatment outcomes,…
Sharp drop in RSV cases so far this winter, with new vaccine taking effect
The introduction of a new vaccine for Respiratory Syncytial Virus (RSV) has…
Journalists Dig Into Vaccine Debate and America’s Obesity Rates
KFF Health News senior correspondent Arthur Allen discussed vaccine infrastructure fragility on…